| 24.73 Delayed Data As of May 24 |  +1.16 / +4.92%Today’s Change | 1.94 Today|||52-Week Range 25.80 | +776.95% Year-to-Date |
| Axsome Therapeutics To Present Data From ASCEND Phase 2 Trial Of AXS-05 In Major Depr... May 21 / GlobeNewswirePNW - Paid Partner Content | Here's Why You'll Regret Ignoring This Biotech Stock Rocket May 19 / MotleyFool.comFOO - Paid Partner Content |
| These 3 Small-Cap Healthcare Stocks Reported Big Updates This Month May 20 / MotleyFool.comFOO - Paid Partner Content |
| Previous close | 23.57 |
| Today’s open | 24.25 |
| Day’s range | 24.01 - 25.36 |
| Volume | 1,138,924 |
| Average volume (3 months) | 1,232,242 |
| Market cap | $768.7M |
| Earnings growth (last year) | +9.31% |
| Earnings growth (this year) | -9.91% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 740.46 |
| Today’s change | Today’s % change | |
|---|---|---|
| ANIPANI Pharmaceuticals ... | +0.04 | +0.06% |
| TWSTTwist Bioscience Cor... | +0.17 | +0.66% |
| MGTXMeiraGTx Holdings PL... | +0.41 | +1.71% |
| RTRXRetrophin Inc | +0.31 | +1.68% |
| Next reporting date | August 5, 2019 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$31.0M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Herriott Tabuteau |
Secretary & Senior Vice President-Operations Mark L. Jacobson |
Corporate headquarters New York, New York |
